Physician profile
Ryan A Straight
NPI 1881986222
$2,035.73
in general payments reported to CMS, 2019-2025
32 companies · $275 in 2025
The $275 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $163 · 2022: $590 · 2023: $674 · 2024: $333 · 2025: $275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,269 · Education: $13.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,269.45 |
| Education | $13.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $457.47 | 2021-2025 | |
| Novo Nordisk INC | $199.74 | 2021-2025 | Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $170.18 | 2021-2024 | Jardiance |
| Dexcom, INC. | $148.36 | 2022-2024 | Dexcom G6 Transmitter |
| Pfizer INC. | $102.22 | 2022-2025 | |
| Glaxosmithkline, LLC. | $88.19 | 2021-2023 | Arexvy, Trelegy Ellipta, Nucala |
| Takeda Pharmaceuticals U.S.A., INC. | $80.60 | 2022-2025 | Glassia, Eohilia |
| Merck Sharp & Dohme LLC | $72.69 | 2022-2024 | Vaxelis, Gardasil 9, Vaxneuvance |
| Otsuka America Pharmaceutical, INC. | $69.24 | 2022-2024 | Rexulti |
| Lilly USA, LLC | $63.70 | 2022-2024 | Jardiance, Emgality, Zepbound |
| Novartis Pharmaceuticals Corporation | $47.38 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $47.31 | 2021-2024 | |
| Daiichi Sankyo INC. | $46.49 | 2022-2024 | Injectafer |
| Teva Pharmaceuticals USA, INC. | $46.40 | 2022 | |
| Inspire Medical Systems, INC. | $45.07 | 2023 | Inspire |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $35.20 | 2022-2024 | |
| Amgen INC. | $28.87 | 2024 | Evenity, Prolia |
| Medtronic, INC. | $27.97 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $25.50 | 2021-2022 | |
| Hologic Sales and Service, LLC | $25.21 | 2023 | Aptima |
| Nestle Healthcare Nutrition INC. | $22.37 | 2023 | |
| Actelion Pharmaceuticals US, INC. | $22.17 | 2025 | Opsynvi |
| Biogen, INC. | $21.11 | 2025 | Zurzuvae |
| Seqirus USA INC | $19.34 | 2025 | Fluad, Flucelvax |
| Astrazeneca Pharmaceuticals LP | $18.43 | 2023 | Breztri |
| Horizon Therapeutics Plc | $17.56 | 2022 | |
| Organon LLC | $17.14 | 2025 | Nexplanon, Nuvaring |
| E.R. Squibb & Sons, L.L.C. | $16.49 | 2023 | Eliquis |
| Eisai INC. | $14.94 | 2021 | |
| Phathom Pharmaceuticals, INC. | $13.91 | 2024 | Voquezna |
| Astellas Pharma US INC | $12.90 | 2023 | Veozah |
| Kowa Pharmaceuticals America, INC. | $11.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Straight listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.